A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
Luxiang Shang(Shandong Provincial QianFoShan Hospital), Baopeng Tang(Xinjiang Medical University), Xianhui Zhou(Xinjiang Medical University), Xiaoxue Zhang(Case Western Reserve University), Huaxin Sun(Xinjiang Medical University), Ling Zhang(Xinjiang Medical University), Yankai Guo(Xinjiang Medical University), Yakun Bo(Xinjiang Medical University)
Cited by 15
Related Papers
Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study
|The Lancet Regional Health - Western Pacific|2022|137
Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants
|bioRxiv (Cold Spring Harbor Laboratory)|2021|66
Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies
|Trends in Cardiovascular Medicine|2020|61
Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
|Frontiers in Physiology|2020|37